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Theiler's virus infection induces an immune-mediated demyelinating disease, providing a relevant animal model of human multiple sclerosis.
VP2121–130-specific CD8
+ T cells in resistant H-2b mice account for the majority of CNS-infiltrating CD8+ T cells. To further study the role of the
CD8+ T cells, we generated a panel of mutant viruses substituted with L, G, or T at the anchor residue (M130) of the VP2121–130 epitope. M130L
virus (M130L-V) with a substitution of M with L displayed similar properties as wild-type virus (WT-V). However, M130G-V and M130T-V
could not establish a persistent infection in the CNS. The level of both virus-specific CD8+ and CD4+ T cell responses is significantly reduced in
mice infected with these variant viruses. While all mutant and wild-type viruses replicate comparably in BHK cells, replication of M130G-V and
M130T-V in macrophages was significantly lower compared to those infected with WT-V and M130L-V. Interestingly, these mutant viruses
deficient in replication in primary mouse cells showed drastically reduced binding ability to the cells. These results suggest that the anchor residue
of the predominant CD8+ T cell epitope of TMEV in resistant mice is critical for the virus to infect target cells and this deficiency may result in
poor viral persistence leading to correspondingly low T cell responses in the periphery and CNS. Thus, selection of the cellular binding region of
the virus as the predominant epitope for CD8+ T cells in resistant mice may provide a distinct advantage in controlling viral persistence by
preventing escape mutations.
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Theiler's murine encephalomyelitis virus (TMEV), an
unenveloped single-stranded positive-sense RNAvirus, belongs
to a genus of family Picornaviridae. TMEV-induced demyeli-
nating disease (TMEV-IDD) provides an excellent infectiousAbbreviations:MS, multiple sclerosis; CNS, central nervous system; TMEV,
Theiler's murine encephalomyelitis virus; TMEV-IDD, TMEV-induced demye-
linating disease; LCMV, lymphocytic choriomeningitis virus.
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show many similarities, among which are immune-mediated
destruction of myelin sheath and gender-biased susceptibility
(Kim et al., 2000). The exact mechanism of immune-mediated
pathology in TMEV-IDD remains elusive. A wealth of
evidence, however, supports the hypothesis that cytokine
release by TMEV-specific Th1 cells leads to the recruitment
and activation of macrophages within the CNS of susceptible
mouse strains. Not only as effectors of demyelination (Liuzzi
et al., 1995; Rossi et al., 1997) but also as regulators of initial
Th1/Th2 differentiation (Palma et al., 2002) in TMEV infection,
macrophages are considered to be a determining factor for
persistent infection (Lipton et al., 2005).
Virus-specific CD8+ T cells are critical in resolving viral
infection by killing virus-infected host cells. Perforin (Palma
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mice with resistant H-2b background developed demyelination
and a low but significant level of clinical diseases. An
immunodominant epitope recognized by >70% CNS-infiltrat-
ing CD8+ T cells and 2 minor epitopes (<10%) were identified
from TMEV-infected C57BL/6 mice (Dethlefs et al., 1997;
Johnson et al., 1999; Lyman et al., 2002). C57BL/6 mice
tolerized in the CD8+ T cell response to the major epitope by
either infusion of soluble epitope peptide or in transgenic mice
expressing the epitope-bearing viral protein become susceptible
to TMEV-induced demyelination (Mendez-Fernandez et al.,
2003). Thus, CD8+ T cell response to the predominant epitope
appears to be critical in maintaining resistance. Although
TMEV-specific CD8+ T cell responses seem to be important in
viral resolution, their role in the pathogenesis/protection in
TMEV-IDD remains controversial (Fuller et al., 2005). A group
of investigators have proposed that cytotoxic CD8+ T cell
response is necessary for clinical manifestation as well (Rivera-
Quinones et al., 1998), based on observation that the lack of
clinical disease in perforin-deficient mice with apparent
demyelination (Murray et al., 1998). Furthermore, CD4+ T
cells may also play a protective role in resistant C57BL/6 mice.
MHC class II-deficient mice are susceptible to TMEV-induced
demyelination and ultimately clinical signs, such as spasticity
and paralysis (Njenga et al., 1996). In addition, antibody-
deficient μMT mice in the absence of CD8+ T cells are also
susceptible to TMEV-induced encephalitis although the defi-
ciency in CD8+ T cells alone is not sufficient to induce clinical
outcome (Kang et al., 2005b).
Thus, identification of the potential role of CD8+ T cells
specific for the predominant TMEV epitope is critically
important in understanding the mechanisms of the protection
and/or pathogenesis of TMEV. In addition, understanding the
compensatory role of CD8+ T cells recognizing minor epitopes
in the absence of T cells recognizing the predominant epitope is
equally important. Furthermore, a variety of viruses, such as
HIV (Allen et al., 2005; Goulder andWatkins, 2004) and LCMV
(Pircher et al., 1990; Velloso et al., 2004), evade potent cytotoxic
T cells by accumulating spontaneous mutations in the epitope
regions. However, no CTL escape mutant from TMEV-infected
animals has been reported so far (Brahic et al., 2005). To address
some of these questions, we constructed a series of ‘in vitro
generated’ CTL escape mutant viruses by single amino acid
substitutions at residue 130 of the predominant VP2 epitope. Our
results in this study clearly demonstrate that mutant viruses
(M130G-V and M130T-V) substituted with residues with low
reactivity to CD8+ Tcells could not establish persistent infection
in the CNS, despite their comparable replication to WT- and
M130L-V in BHK-21 cells. The levels of both VP2121–130-
specific CD8+ Tcells and virus-specific CD4+ Tcells in the CNS
were significantly reduced in mice infected with these mutant
viruses in contrast to those in mice infected with WT-V or
M130L-V. Interestingly, such drastic reduction in CD8+ T cell
response to VP2121–130 was not accompanied by a compensatory
increase of other epitope-specific CD8+ T cells. This unexpect-
edly low Tcell response and viral persistence apparently resulted
from the inability of the mutant viruses to bind their cellularreceptors. These results strongly suggest that the TMEV
VP2121–130 CD8
+ T cell epitope region is critical for viral
infection of target cells. The necessity of the intact epitope region
for viral binding to the target cells may limit emergence of CTL
escape mutants in this region.
Results
Hydrophobicity and size of the amino acid residue at the
position VP2130 affect binding of VP2121–130 peptide to H-2D
b
molecule
The VP2 130M residue is believed to be an anchor residue of
the predominant H-2Db-restricted VP2121–130 epitope. To study
the role of CD8+ T cells in C57BL/6 mice, we substituted the
VP2130 methionine (M) residue with 17 different amino acids,
excluding P and C which result in drastic structural changes
(Fig. 1A). It was previously shown that incubation of RMA-S
cells with MHC class I-binding peptides has shown to enhance
surface expression of the MHC class I molecules on these cells
by stabilizing the peptide-MHC complex (Ljunggren et al.,
1990). As expected, the peptides substituted with consensus
anchor residues (I and L) stabilized comparable levels of surface
Db expression (Fig. 1B). Interestingly, surface MHC class I
molecules were also stabilized by peptides substituted with
some other hydrophobic non-consensus amino acids, such as A,
F, and V, while none of polar amino acid substitutions yielded
such stabilization. In addition to hydrophobicity, the size of
amino acid also seems to play a role, as small G and large W
which are both hydrophobic could not stabilize surface
expression. Stabilization of surface Kb expression by the analog
peptides was also analyzed. However, no significant stabiliza-
tion was observed by any of the peptides utilized, indicating that
these peptides do not bind Kb molecules (data not shown).
Binding affinity of peptides to Db molecules affects
immunological reactivity by CD8+ T cells
To correlate the binding ability of H-2Db to peptides with
specific CD8+ T cell activation, we re-stimulated freshly
isolated CNS-infiltrating MNC from mice at 8 days post
TMEV-infection with a panel of substituted peptides and
examined their ability to stimulate intracellular and extracellular
interferon-γ production, as well as target cell lysis (Fig. 1C). All
the peptides with high binding affinity, i.e., native (130M) and
substituted with A, F, I, L, and V, induced higher levels of
IFN-γ production. In addition, these peptides induced more
effective lysis of EL-4 cells loaded with the peptides. These
results indicate that substituted peptides with high affinity to
MHC I molecules display strong activation of epitope-specific
CD8+ T cells. However, peptides with low affinity induce
varying patterns of immunological reactivity in CD8+ T cells.
The affinity of a peptide for Db correlates well with its ability to
induce IFN-γ production and target cell lysis by CD8+ T cells,
e.g., poor Db-binding peptides substituted with N, Q, R, or S
could neither up-regulate IFN-γ production in CD8+ T cells nor
lead to lysis of target cells (Fig. 1C). Peptides substituted with
Fig. 1. Sequence and binding affinity of peptides with a single amino acid change at the VP2130 residue within the immunodominant epitope (VP2121–130) in C57BL/6
mice. (A) The conserved binding motif of H-2Db molecule and consensus MHC-binding anchor residues (arrows) at positions 5 and 10 (Rammensee et al., 1995) are
shown. Representative peptide sequences, which contain some substitutions of native residue (M) at the 10th position of VP2121–130 epitope are shown and the
changed residue is marked by a rectangle. (B) The peptides, substituted at the anchor position, were used to assess their binding properties towards H-2Db. Surface
expression of H-2Db on RMA-S cells was examined by flow cytometric analysis. The level of surface MHC class I molecules is expressed as median fluorescence
intensity (MFI) (mean±SD). The average of 3 independent experiments is shown. (C) Immunological reactivity of peptides on CNS-infiltrating CD8+ T cells from
infected C57BL/6 mice at 8d post-infection. Intracellular IFN-γ expression in response to peptides was assessed by flow cytometry. IFN-γ-secreting CD8+ T cells in
2×104 CNS infiltrates were enumerated by ELISPOTafter incubation with each peptide and irradiated 1×106 splenic cells as antigen presenting cells. Specific lysis of
EL-4 cells, loaded with each peptide, by CNSMNCwas analyzed in a standard 51Cr release assay (E:T=100:1). IFN-γ ICS, ELISPOTand CTL assays were performed
with aliquots of the identical pooled CNS-infiltrating mononuclear cell suspension. Values given for individual panels are the mean of percentage or spots of two to
three separate experiments with background subtracted (mean±SD). *p<0.05; **p<0.005; ***p<0.001 (Student's t test).
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production. However, the level of IFN-γ production by the
peptides did not correspond to their ability to lyse the target cells
(e.g., high lysis of target cells loaded with 130K and Ypeptides,
but low lysis with 130G and H). These data suggest that low-
affinity peptides are unable to stably bind to class I molecules
which is required to transmit activation signals through TCR
complex on CD8+ Tcells for IFN-γ production. However, some
such weak interactions may be sufficient for cytolytic function.
It is also interesting to note that intracellular IFN-γ expression
did not always correlate with the number of IFN-γ-secreting
CD8+ T cells. The differences, particularly by intermediate
inducers (130E, N and R), may reflect that secretion of IFN-γrequires stronger stimulatory signal than intracellular cytokine
expression (Horton et al., 2004).
Wild-type and mutant viruses, containing a single amino acid
substitution at VP2130(M) with L, T, or G replicate similarly in
BHK cells
To investigate the effect of a single amino acid substitution at
the anchor position VP2130 on induction of virus-specific T cell
responses in vivo, we generated several mutant viruses by site-
directed mutagenesis at the position as described in Fig. 2A.
The amino acids to be substituted were selected based on the
affinity of each altered peptide for Db and its reactivity to
Fig. 2. Replication of wild-type and mutant viruses containing a single amino acid substitution at VP2130 in BHK 21 cells. (A) Schematic diagram of site-directed
mutagenesis of TMEV BeAn strain. Amino acid and DNA sequences of wild-type and selected mutant viruses are presented. (B) In vitro growth of wild-type and
mutant viruses in BHK cells. Viruses recovered from the cultures at the indicated time point were assayed for viral replication by plaque assay. Viral titer is expressed as
log10 PFU/ml (mean of triplicates±SEM).
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tion with L, which is one of the consensus Db motifs retaining
strong affinity to Db and vigorously stimulating CD8+ T cells,
substitutions with G and T, inducing intermediate levels of
IFN-γ production and low cytotoxic activity, and substitution
with S, evoking only marginal level of CD8+ T cell stimulation.
As a positive control, WT virus created from the same
expression vector of TMEV BeAn strain (pSBW) was included
(Fig. 2A). All the viruses used, except M130S-V, demonstrate
comparable growth in BHK cells (Fig. 2B). However, M130S-
V showed a significant growth deficiency by one order of
magnitude at 14 h post-infection and thereafter. Therefore,
M130S-V was not included in subsequent studies.
Viral replication in BHK cells does not correlate with in vivo
viral persistence and peripheral immune responses
To examine viral replication in vivo, viral titers were
measured in the brains and spinal cords of mice infected with3×106 pfu of each virus. At 8 days post-infection, the level of
viral titers in M130L-V-infected mice was comparable to that of
WT-V-infected mice. However, M130T-V and M130G-V
showed 10-fold and 10,000-fold lower viral titers in the CNS
respectively compared to WT-V (Fig. 3A). At 21 days post-
infection, however, no detectable viral titers from any of the
virus-infected mice were observed in 3 repeated experiments.
Since it has previously shown with CVB3, another picornavirus
that some replicating viral genomes failed to produce lytic
plaques on infected cells (Feuer et al., 2002; Kim et al., 2005),
the viral message levels in the CNS were further assessed.
Analysis of viral message levels in these mice using real-time
PCR indicated that viral message levels at 8 days post-infection
are closely correlated with the levels of viral replication
determined by plaque assay (Fig. 3A). As expected, the viral
message levels at 21 days post-infection were low although the
levels of M130L-Vand M130G-V were higher than that of WT-
V. Nevertheless, the variant viruses appeared to be replicated at
a low level in the CNS. The low or undetectable level of TMEV
163J. Myoung et al. / Virology 360 (2007) 159–171messages in the CNS of C57BL/6 mice after 21 days post-
infection was consistent with the previous report (Lipton et al.,
2005). This may reflect the balances between the reduced levels
of virus-specific CD8+ T cells and viral infectivity of the variant
viruses to the host cells. Nevertheless, such differences do not
appear to be strong enough to alter the pathogenic property of
the viruses.
As TMEV-specific antibody responses were previously
shown to be involved in resistance to viral infection and low
viral persistence in C57BL/6 mice (Kang et al., 2005b), thelevel of virus-specific IgG responses in the serum was
analyzed. As shown in Fig. 3B, significantly lower antibody
responses were induced in M130G-V and M130T-V-infected
mice compared to those from mice infected with either WT or
M130L-V (p<0.05 at all dilution points). Therefore, the
virus-specific antibody response does not appear to be
responsible for early viral clearance from the CNS. To test
whether higher peripheral T cell responses in M130G/T-V-
infected mice are responsible for early viral clearance, splenic
CD4+ and CD8+ T cell responses to viral epitopes were
assessed by ELISPOT assay (Fig. 3C). The level of IFN-γ-
secreting virus-specific CD4+ T cells was not affected in any
of the experimental groups, while that of CD8+ T cells was
greatly reduced in M130G/T-V-infected mice compared to
M130L-V or WT-V-infected animals (p<0.005). Therefore,
peripheral immune responses to the virus do not seem to be
responsible for the unusually rapid clearance of M130G-V
and M130T-V.
M130G-V and M130T-V are unable to induce CNS-infiltrating
CD8+ T cell responses to either native or altered epitopes
Although infection with M130G/T-V did not induce
peripheral CD8+ T cells specific for the native epitope
(VP2120–130 0M), such CD8
+ T cells may be detectable in the
CNS, the site of viral persistence. In addition, it is equally
possible that these mutant viruses may induce CD8+ T cells
preferentially reactive to their own altered epitopes. To test this
possibility, we assessed the epitope reactivity of CD8+ T cells in
the CNS of mice by intracellular IFN-γ production following
stimulation with the native epitope peptide and altered peptides
(Fig. 4). WT-V-infected mice resulted in 53% of CNS-
infiltrating CD8+ T cells reactive to the native 130M, 20% to
130L, 7% to 130G and 4% to 130T (Fig. 4A). M130L-V
containing a consensus binding residue for Db induced a
significant level of CD8+ T cells reactive to 130M (41%) andFig. 3. Comparison of viral persistence and peripheral immune responses in WT
or mutant virus-infected mice. (A) Viral load in the CNS (pooled brains and
spinal cords from at least three mice per group) of C57BL/6 mice infected with
indicated viruses was determined by plaque assay at 8 and 21 days post-
infection. M130L-V-infected mice showed comparable viral load to wild-type
virus at day 8 post-infection while the level of recovered virus from M130G-V
and M130T-V-infected mice was significantly lower than those from M130L-V
or WT-V infected mice (*p<0.05; **p<0.001). Detection limit of plaque assay
was <50 PFU/CNS. Viral levels below detectable by plaque assay, were
indicated as not detectable (ND). Real-time PCR of cDNAs from the CNS of
mice infected with WTand variant TMEV for 8 and 21 days was performed with
specific primers. Data are expressed as means±SD for triplicate determinations.
*p<0.05; **p<0.005; ***p<0.001 (Student's t test). (B) TMEV-specific IgG
response was analyzed by ELISA. Pooled sera from 3 mice infected with the
indicated virus were used for the assessment. The level of virus-specific IgG in
the sera of M130G-V and M130T-V-infected mice was significantly lower
compared to that of M130L-V and WT-infected animals (p<0.05). C, Epitope-
specific CD8+ and CD4+ T cell responses were assessed by ELISPOT assay.
Spleen cells (1×106) from 3 mice infected with the indicated virus were
incubated in the presence of VP2121–130 or a mixture of CD4
+ T cell epitopes
(VP425–38 and VP2206–220) for 16 to 18 h. M130G/T-V induced significantly
lower number of epitope-specific CD8+ T cells in the spleen compared to WT-V
(*p<0.05).
Fig. 4. Epitope-specific IFN-γ-producing CD8+ T cell in the CNS of WT or mutant virus-infected mice. (A) CNS-infiltrating cells were stimulated with indicated
peptides at 2 μM for 6 h. Cells were stained for both CD8 and intracellular IFN-γ followed by flow cytometric analysis. The percentage of IFN-γ+CD8+ T cells is
shown in the upper left box of each plot. Data are representative of 3 independent experiments. (B) CNS-infiltrating cells from mice at 8 days and 21 days post-
infection were stimulated with the predominant (VP2121–130) or a mixture of minor epitope peptides (VP2165–173 and VP3110–120) for 6 h and the percentage of
IFN-γ+CD8+ Tcells was determined. (C) Proportion of epitope-specific CD8+ Tcells (top panel), total number of CNS-infiltratingMNC (middle panel), and the number
of epitope-specific CD8+ T cells in the CNS (bottom panel) is shown. Values given are the mean of percentage or numbers of at least two independent experiments
(mean ± SD). (D) Comparison of Db-VP2121–130 tetramer-positive and VP2121–130-specific IFN-γ-positive CNS-infiltrating CD8
+ T cells. CNS infiltration of specific
CD8+ T cells in mice infected with M130G-Vand M130T-V was significantly lower compared to that in mice infected with WT-Vor M130L-V. *p<0.05; **p<0.01.
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(130M)-reactive CD8+ T cells recognized 130L peptide in
M130L-V-infected animals, while only 37% of 130M-specific
CD8+ T cells are 130L-reactive in WT-V infected mice,
suggesting that M130L-V infection preferentially induce CD8+
T cells favoring reactivity to 130L within the T cell repertoire
reactive to 130M. However, M130L-V failed to induce a higher
level of CD8+ T cells reactive to the altered epitope compared to
the native epitope. In addition,M130G-VandM130T-V failed to
induce vigorous CD8+ Tcell responses to either the native 130M
or their own substituted epitopes, 130G and 130T, respectively
(p<0.001). Furthermore, there was no significant compensatory
increase in the CD8+ T cell population specific for minor
epitopes to balance the reduced level of CD8+ Tcells specific for
the predominant epitope (Fig. 4B). Thus, the reduction of CD8+
T cells reactive to the epitope region appears to reflect inability
of the variant viruses to induce CD8+ T cell responses (Fig. 4C).
In order to examine further the possibility that these infected
mice may induce comparable level of specific CD8+ T cells
which do not produce IFN-γ, the presence of epitope-specific
CD8+ T cells in the CNS was assessed using Db-130M (WT)
tetramer (Fig. 4D). Similar levels of CD8+ T cells reacted with
the tetramer compared to the intracellular IFN-γ production.
Therefore, it is most likely that M130G/T-V fail to induceFig. 5. Epitope-specific IFN-γ-producing CD4+ T cells in the CNS of WTor mutant v
mixture of CD4+ T cell-specific epitopes (VP2206–220 and VP425–38) for 6 h. Cells we
cells is shown on the upper left corner of each plot. Data are representative of 3 indepe
of 2–3 independent experiments by FACS analysis. Proportion of epitope-specific C
panel), and the number of epitope-specific CD4+ T cells in the CNS (bottom panel)cognate CD8+ T cell responses to this epitope region in infected
animals.
Both M130G-V and M130T-V induce weak virus-specific
CD4+ T cell responses in the CNS
Since the low levels of virus-specific CD8+ T cell and
antibody responses paralleled the inability of M130G/T-V to
persist in vivo, we next sought to assess the level of epitope-
specific CD4+ T cells, which were shown to be important in
virus clearance in C57BL/6 mice (Njenga et al., 1996). The
levels of CD4+ T cell responses to two representative
immunodominant epitopes, VP2206–220 and VP425–38 were
assessed by intracellular IFN-γ production (Fig. 5) as shown
previously (Kang et al., 2005a). Like CD8+ Tcell responses, the
proportion (p<0.05) and the number (p<0.001) of epitope-
specific CNS CD4+ T cells induced following infection with
M130G/T-V were significantly lower at 8 days post-infection
compared to that induced by WT-V and M130L-V (Fig. 5). In
addition, the overall CD4+ T cell infiltration to the CNS was
also significantly reduced following infection with these mutant
viruses. Therefore, as seen for the antibody and CD8+ T cell
responses, these variant viruses except M130L-V, are unable to
induce strong TMEV-specific CD4+ T cell responses.irus-infected mice. (A) Isolated CNS-infiltrating MNC were re-stimulated with a
re stained for CD4 and intracellular IFN-γ. The percentage of CD4+ and IFN-γ+
ndent experiments. (B) Histograms represent the mean of percentage or numbers
D4+ T cells (top panel), total number of CNS-infiltrating CD4+ T cells (middle
is shown.
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macrophages
It is conceivable thatM130G/T-Vmay not be able to replicate
to the extent of WT-Vand M130L-V in mouse cells, resulting inFig. 6. Viral replication in primary macrophages and binding to primary cells
derived from C57BL/6 mice. (A) Primary macrophages were infected with each
virus and the cell culture supernatant was assessed for virus titers by plaque
assay. Values given represent the number of plaques per 106 peritoneal
macrophages (mean±SD). Statistical analysis was performed by Student's t test.
*p<0.05; **p<0.005. Viral binding to macrophages (B) or DC (C) derived from
C57BL/6 mice was assessed. In all plots, filled histograms and open histograms
represent staining with an isotype control Ab and monoclonal Ab specific to
TMEV, respectively. Numbers in each histogram plot indicate subtracted MFI
value (MFI with TMEV-specific antibody−MFI with control Ab).the lack of viral expansion/replication and poor induction of
immune responses. To explore this possibility, the replication
levels of wild-type and mutant viruses in thioglycollate-induced
peritoneal exudate macrophages were assessed (Fig. 6A), as this
cell type is known to be the main reservoir of TMEV (Clatch et
al., 1990; Rossi et al., 1997). The level of M130G/T-V
replication in macrophages was significantly lower (p<0.05
for M130G-V, p<0.005 for M130T-V) compared to that of WT-
V or M130L-V. Therefore, the lack of viral persistence in the
CNS of mice infected with these mutant viruses may reflect the
deficient replication in mouse host cells. To further test whether
this low viral replication in macrophages is due to the inability of
M130G/T-V to bind to the cells, we determined the ability of
these viruses to bindmacrophages. Interestingly, bothM130G-V
and M130T-V bind macrophages far less well compared to WT-
V. M130L-V, which shows viral replication similar to WT-V,
binds the macrophages better than M130G/T-V, but less well
compared to WT-V (Fig. 6B). The differences in the replication
levels of M130G-Vand M130T-V despite a comparable level of
macrophage binding suggest a potential involvement of post-
attachment steps. Therefore, viral binding above a certain
threshold by M130L-V may be sufficient for comparable viral
replication. Similar binding deficiencies of the mutant viruses
were observed with bone-marrow-derived DC (Fig. 6C). The
deficiencies in DC binding by these viruses may also negatively
affect the ability to induce strong T cell responses specific for
viral determinants, in particular CD8+ T cell responses.
Discussion
The importance of CD8+ T cells in conferring resistance to
TMEV infection has been extensively studied not only by
employing various mice deficient in immune-related genes
(Begolka et al., 2001; Palma et al., 2001; Pullen et al., 1993)
or transgenic expression of H-2Db (Mendez-Fernandez et al.,
2003), but also by enumerating virus-specific CD8+ T cells in
the CNS of differentially susceptible mice (Kang et al., 2002b;
Lyman et al., 2004). One immunodominant CD8+ T cell
epitope (VP2121–130) was identified (Dethlefs et al., 1997;
Johnson et al., 1999) and shown to be critical for maintaining
resistance in genetically resistant C57BL/6 mice (Lyman et al.,
2004; Mendez-Fernandez et al., 2003). However, the involve-
ment of CD8+ T cells in the pathogenesis of clinical disease
remains to be elusive (Fuller et al., 2005; Murray et al., 1998;
Rivera-Quinones et al., 1998). To study further the role of
epitope-specific CD8+ T cells in TMEV-IDD, we have first
analyzed a panel of the epitope peptides, containing single
amino acid substitutions at position VP2130 (M130) for their
ability to interact with class I molecules and stimulate specific
CD8+ T cells. Interestingly, some apparent non-binders were
able to result in cytolytic activity and/or IFN-γ production
(Fig. 1). It has also previously been shown that some MHC
class I-binding peptides failed to induce CTL with effector
functions such as target cell lysis or cytokine expression
(Feltkamp et al., 1994; Lyman et al., 2002). The discrepancies
between binding and stimulatory function of the peptides may
reflect the insensitivity of the MHC-binding assay (Feltkamp
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subpopulations and/or stimulatory signal requirements (Ander-
sen et al., 2000). Altered epitope peptides (130F/I/L) with high
MHC-binding affinity stimulated specific CD8+ T cells to
produce high level of IFN-γ (Fig. 1). Likewise, peptides
(130K/W/H) with low affinity for MHC class I molecules
generally induced low level of IFN-γ.
Based on the above binding and stimulation studies with
altered peptides, we generated variant TMEV carrying the
altered epitope region by introducing non-charged polar or
charged amino acid substitutions at the position of VP2130.
Intriguingly, none of charged amino acid substitutions (e.g., D,
E, K, etc.) produced viable viruses (data not shown), indicating
the importance of the hydrophobic nature of this anchor residue
for viral replication. In contrast, TMEV (M130G-V and
M130T-V) substituted with non-charged polar amino acid (G
and T, respectively) at the position were able to replicate
comparably to the wild-type virus or virus with L substitution
(M130L-V) in BHK 21 cells (Fig. 2B). Therefore, some of
these substitutions appear to be well tolerated for viral
replication in BHK cells. In contrast, these mutant viruses
(M130G/T-V) showed significantly lower replication (p<0.05
and p<0.001, respectively) compared to WT-V in primary
macrophages (Fig. 6A), suggesting that the replication/
infection of these mutant viruses is severely compromised in
mouse primary cells. Further studies demonstrated that the
poor replication of these mutant viruses appears to reflect their
inefficient binding to the cells in general (Fig. 6B). As
macrophages are known to be a major viral reservoir, antigen
presenting cells, as well as one of the main effectors of
demyelination, the inability of mutant viruses to establish
infection in this cell type is likely to result in inferior viral
persistence and virus-specific immune responses in vivo. This
binding deficiency is not limited to macrophages as these
variant viruses showed similar binding reductions to DC
although the degree may be slightly different depending on
the cell types (Fig. 6C). Therefore, these viruses are most likely
defective in infection of many different host cell types which
may result in some discrepancies between the levels of viral
persistence in the CNS (Fig. 3) and in vitro assays for binding
and replication (Fig. 6). In addition, DC are known to be the
most important APC in T cell responses to virus in the periphery
and the CNS (Granucci et al., 2005; Greter et al., 2005;
McMahon et al., 2005). Thus, the reduced levels of virus
binding/infection to DC may also contribute to the poor T cell
responses to the mutant viruses. Since the precise correlation of
CNS viral persistence to one factor alone is not observed, all of
these and perhaps additional unknown factors may collectively
influence the level of viral persistence in vivo.
It has previously been reported that BeAn and DA strains of
TMEV use sialic acid as co-receptors for cell entry (Shah and
Lipton, 2002; Zhou et al., 1997, 2000). The residues known to
be involved in interaction of TMEV with sialic acid moiety are
located in close proximity to VP2-M130, suggesting that
alteration of M130 may influence on receptor binding
(Supplemental Fig. 1). However, it is unlikely that this residue
is directly involved in interacting with sialic acid since M130G/T-V are capable of infecting/replicating in BHK cells compar-
ably to WT viruses (Fig. 2). In addition, the VP2130 residue is
located in one of β-sheets of the VP2 chain and not in the loops
containing residues interacting with the sugar moiety (Supple-
mental Fig. 1A). Furthermore, this residue is not exposed on the
surface of the TMEV protomer required for potential interaction
with sialic acid (Supplemental Fig. 1B). However, it is
conceivable that substitution of M with G or T at the position
might induce a more global change on virion structure such that
M130G/T-V display compromised interactions with cellular
receptor(s) and/or co-receptors, including sialic acid residues.
Nevertheless, these viruses appear to retain reduced but some
ability to infect macrophages. Certain variant TMEV similarly
substituted at the position VP2125 within the predominant
epitope region (e.g., S125G-V) also resulted in poor binding to
macrophages, deficiencies in viral persistence and CD8+ T cell
response in the CNS (Supplemental Fig. 2). Therefore, not only
the M130 residue but also adjacent residues may display similar
effects. These results support the importance of this epitope
region in the binding to the host cells for resistant C57BL/6
mice. Selection of the cellular binding region of the virus as the
predominant epitope for CD8+ T cells may have a distinct
advantage in controlling viral persistence, as an establishment
of escape mutant viruses in resistant H-2b mice would be
extremely difficult without compromising the infectivity. In
fact, no naturally occurring CTL escape mutants at this region
have been reported.
It is interesting to note that in resistant C57BL/6 (H-2b)
mice, 50–70% of infiltrating CD8+ T cells are VP2121–130-
specific and are critical for viral clearance (Lyman et al., 2004;
Mendez-Fernandez et al., 2003). Despite the predominance of
this single CD8+ T cell epitope throughout the infection, we
have not been able to isolate escape mutants, and none have
been reported as of yet. It is also intriguing to note that the
CD8+ T cell response induced by a mutant virus (e.g., M130L-
V), even with similar levels of viral persistence and immune
responses, preferentially react with the native epitope, M130
rather than their own mutated epitope, M130L. Our results in
this study demonstrate that viruses with non-conservative
amino acid substitutions at VP2130 are compromised in binding
to cellular receptors on primary cells from C57BL/6 mice,
leading to reduced viral persistence in vivo. Therefore, the lack
of emergence of mutant viruses at the epitope region may
reflect the importance of this region in maintaining viral
persistence and/or in determining host range and tissue
tropism. Our observation is consistent with the recent
suggestion by Brahic and colleagues that “a high fitness
cost” may be required for mutation in this epitope since it is
conserved by all Theiler's virus strains despite the selection
pressure of CD8+ T cells (Brahic et al., 2005). Interestingly but
not surprisingly, these mutant viruses also displayed poor
binding to macrophages derived from H-2s-bearing SJL/J mice
(data not shown). These preliminary results suggest that this
region might be involved in virus binding regardless of their
MHC haplotype. Further crystallographic structural studies
with the mutant viruses may reveal the potential alterations in
the putative cellular receptor binding region of the virus. In
168 J. Myoung et al. / Virology 360 (2007) 159–171addition, these variant viruses may also provide an important
tool in identifying cellular receptor(s) for TMEV infection.
Materials and methods
Animals
Female C57BL/6 mice from the Charles River Laboratories
(Charles River, MA) through the National Cancer Institute
(Frederick, MD) were housed in the Animal Care Facility of
Northwestern University. Animal experiments were conducted
according to the protocols approved by Northwestern university
animal care and use committee.
Cell lines
The EL-4 (H-2Db) and BHK-21cell lines were obtained from
American Type culture collection (Bethesda, MD) and was
maintained in RPMI 1640 supplemented with 5% FBS. RMA-S
cell line was obtained from Dr. Jeffrey Bluestone (University of
California, San Francisco) with permission from Dr. Klas Karre
(Karolinska Institute, Stockholm, Sweden).
Synthetic peptides and antibodies
All peptides used were synthesized with the rapid
multiple peptide synthesis system (RaMPS; Dupont Co.,
Wilmington, DE) and used as described previously (Kang et
al., 2002b). All antibodies used were purchased from BD
Pharmingen.
Virus preparation and infection
Viruses used in this study were generated, propagated, and
titered in BHK-21 cells grown in Dulbecco's modified Eagle
medium supplemented with 7.5% donor calf serum. For
intracerebral (i.c.) infection, 30 μl virus solution, containing
3 × 106 pfu, was injected into the right cerebral hemisphere of
6- to 8-week-old mice anesthetized with isoflurane.
Site-directed mutagenesis and mutant virus generation
A full-length expression clone pSB3 (Pevear et al., 1987)
was modified to reflect the nucleotide sequence of our highly
pathogenic BeAn S2 stock. The regions of pSB3 differing in the
sequence of BeAn S2 (Genbank Accession number
#DQ401688) were replaced with those of S2. In addition, 12
nucleotides between T7 promoter and 5′ untranslated region of
the TMEV genome were deleted and TT were added
immediately after T7 promoter. Plasmid constructs for mutant
viruses, harboring a single amino acid substitution in the
predominant CD8+ T cell epitope in C57BL/6, were generated
using QuikChange® II XL Site-directed Mutagenesis Kit
(Stratagene, Cedar Creek, TX). A mutation was introduced
into an expression cDNA clone (pSBW) of TMEV BeAn strain
(Accession number #DQ401688) according to the manufac-
turer's instruction. Briefly, two complementary mutagenicoligonucleotides were designed so that those oligonucleotides
bind to pSBW except the target site. Mutant viral DNA was
amplified with pfu Turbo® (Stratagene, Cedar Creek, TX) based
on polymerase chain reaction. Parental strands were destroyed
by Dpn I with the digestion mixture and subsequently used to
transform JM109 E. coli competent cells. Sequences were
verified at the Sequencing Core Facility of Northwestern
University. Viral RNA was then transcribed in vitro from wild-
type or mutated pSBW using T7 RNA polymerase in the
presence of RNasin, an RNase inhibitor (Promega, Madison,
WI). The integrity and size of viral RNA was verified on 1.2%
agarose gel. Each viral RNA was transfected into BHK cells
using Lipofectamine 2000® (Invitrogen, Carlsbad, CA). Cyto-
pathic effect was observed from 3 days post-transfection.
Viruses were harvested 5–7 days after transfection and re-
infected into BHK cells to further amplify viruses.
Viral replication assay
Wild-type or mutant virus was infected at MOI 10 into BHK
cells with rocking and resting for 1 h followed by extensive
wash. Cells were then cultured for various time periods at 33 °C.
Both cells and supernatants were harvested and kept at −70 °C
until use. To obtain macrophages, thioglycollate (1 ml of 3%)
medium (Difco, Detroit, MI) was injected into peritoneal cavity
of C57BL/6 mice and peritoneal exudate cells were collected
3 days later. Cells (2×106) were washed and then seeded into a
24-well plate for 2 h at 37 °C. After removal of non-adherent
cells, the remaining adherent cells were used for viral infection
study. Wild-type and mutant viruses were infected at MOI 10 at
room temperature for 1 h, unbound viruses were removed, and
then further cultured in 1 ml of RPMI 1640 medium. After 24 h,
culture supernatants were used to determine the level of
productive viral replication by plaque assay on BHK mono-
layers (Fuller et al., 2005).
Semi-quantitative real-time PCR
Total RNA was isolated from tissue homogenates using
Trizol® Reagent (Invitrogen, Carlsbad, CA), and resuspended
in 0.1% DEPC water containing RNasin® (Promega, Madison,
WI). cDNA was synthesized by utilizing SuperScript III
Reverse Transcriptase (Invitrogen, Carlsbad, CA) and oligo
dT primers and then amplified using the Bio-Rad iCycler iQ
system (Bio-Rad Laboratories, Hercules, CA). Real-time PCR
(40 cycles) was carried out using iQ SYBR Green supermix
(Bio-Rad Laboratories) with the following sequence specific
primers. GAPDH: 5′-AACTTTGGCATTGTGGAAGG-3′ and
5′-ACACATTGGGGGTAGGAACA-3′; TMEV: 5′-CTGCA-
ATTGGAACTGACCCAGATG-3′ and 5′-ATGTCGTGACA-
CAGCCAGAGAT-3′.
Isolation of CNS-infiltrating mononuclear cells (MNC)
Mice were perfused with 40ml of sterile Hank's balanced salt
solution (HBSS) and excised brains and spinal cords were
homogenated. CNS-infiltrating MNC were then enriched in the
169J. Myoung et al. / Virology 360 (2007) 159–1711/3 bottom fraction of a continuous Percoll (Pharmacia,
Piscataway, NJ) gradient after centrifugation for 30 min at
27,000×g as described previously (Fuller et al., 2005).
Peptide binding assay on RMA-S cells
For H-2Db binding assays, RMA-S cells were loaded with
various peptides at final 40 μM for 16–18 h at 37 °C as
described previously (Lyman et al., 2002). Levels of surface
MHC class I molecule expression were assessed by flow
cytometric analysis using FITC-conjugated mouse monoclonal
antibodies specific for H-2Db (Clone CTDb; Cedarlane
Laboratories Ltd., Ontario, Canada) or H-2Kb (Clone CTKb;
Cedarlane Laboratories).
Intracellular staining of cytokine production
Freshly isolated CNS-infiltrating MNC were cultured in 96-
well round bottom plates in the presence of relevant or control
peptide as described previously (Lyman et al., 2004).
Allophycocyanin-conjugated anti-CD8 (clone Ly2) or anti-
CD4 (clone L3T4) antibody and PE-labeled rat monoclonal
anti-IFN-γ (XMG1.2) antibody were used for intracellular
cytokine staining. Cells were analyzed on a Becton Dickinson
FACS Calibur or FACS Sort flow cytometer. Live cells were
gated based on light scatter properties.
IFN-γ ELISPOT assay and antibody ELISA
The number of antigen-specific IFN-γ-secreting CD8+ T
cells (2×104 CNS-infiltrating MNC) was enumerated by
ELISPOT assay after 18 h of ex vivo stimulation with various
peptides at final 2 μM with 1×106 irradiated splenic cells.
Plates were further incubated with biotin-conjugated anti-IFN-γ
antibody (Endogen, Rockford, IL), followed with streptavidin-
HRP and then developed using 3-amino-9-ethyl-carbazole
(Sigma-Aldrich, St. Louis, MO) as described previously
(Kang et al., 2002a). Antibody response was examined using
UV-TMEV-coated plates by ELISA starting with 1/100-diluted
serum samples from infected animals as described elsewhere
(Kang et al., 2002a).
CTL assay
EL-4 cells were loaded with WT or mutant peptides and used
as target cells to analyze induction of each peptide-reactive CD8+
Tcells in the CNS using a standard 51Cr release assay as described
previously (Lyman et al., 2002). After extensive wash, peptide-
loaded 51Cr-EL-4 target cells (3×103) were added to varying
numbers of fresh CNS effector cells followed by incubation at
37 °C for 6 h. Supernatants were collected and the mean
radioactivity values were calculated from duplicate wells.
Percentage of specific lysis was computed according to the
formula: ((experimental 51Cr release−spontaneous 51Cr release) /
(maximum 51Cr releasewith 1%TritonX-100−spontaneous 51Cr
release))×100%. Spontaneous lysis was less than 15% through-
out the assays.Generation of bone-marrow-derived dendritic cells (BM DC)
BM cells harvested from femurs and tibias of C57BL/6 mice
were cultured in 24-well plates (Corning Coster, Cambridge,
MA) (2×106/well) in 1 ml culture medium supplemented with
20 ng/ml murine rGM-CSF (Peprotech, Rocky Hill, NJ). The
selection procedures were similar to those reported initially by
Inaba et al. (1992) with minor modifications as described (Hou
et al., 2003). On day 5, DC were harvested, washed twice and
used in subsequent experiments.
Virus-cell binding assay
Single-cell suspensions of BM DC or peritoneal exudate
cells (PEC) were incubated for 1 h at 4 °C with TMEV BeAn
(MOI=100), washed extensively with ice-cold PBS, and fixed
in 1% paraformaldehyde as described by Mena et al. (2004).
Fixed cells were washed with PBS, blocked with normal goat
serum and then reacted with the 8C monoclonal Ab to the
TMEV capsid protein (Crane et al., 1990) followed by FITC-
conjugated goat F(ab')2 anti-mouse immunoglobulin (Bio-
Source International, Camarillo, CA). Labeled cells were
analyzed on a FACS Calibur flow cytometer using the
CellQuest software program. Mean log fluorescence intensity
(MFI) values were obtained by subtracting the MFI of the
isotype control from the MFI of the 8C monoclonal Ab stained
sample.
Statistical analysis
Data are shown as mean±SD of either 2–3 independent
experiments or one representative from at least three indepen-
dent experiments. The significance of differences in the mean
values was determined by Student's t test. p Values of <0.05
were considered statistically significant.
Acknowledgments
This study was supported by NS23349, NS28752 and
NS33008 from the National Institutes of Health, United States
Public Health Services and RG 3392A5 from the National
Multiple Sclerosis Society.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.virol.2006.09.045.
References
Allen, T.M., Altfeld, M., Geer, S.C., Kalife, E.T., Moore, C., O'Sullivan, K.M.,
Desouza, I., Feeney, M.E., Eldridge, R.L., Maier, E.L., Kaufmann, D.E.,
Lahaie, M.P., Reyor, L., Tanzi, G., Johnston, M.N., Brander, C., Draenert,
R., Rockstroh, J.K., Jessen, H., Rosenberg, E.S., Mallal, S.A., Walker, B.D.,
2005. Selective escape from CD8+ T-cell responses represents a major
driving force of human immunodeficiency virus type 1 (HIV-1) sequence
diversity and reveals constraints on HIV-1 evolution. J. Virol. 79,
13239–13249.
170 J. Myoung et al. / Virology 360 (2007) 159–171Andersen, H., Dempsey, D., Chervenak, R., Jennings, S.R., 2000. Expression
of intracellular IFN-g in HSV-1-specific CD8+ T cells identifies distinct
responding subpopulations during the primary response to infection.
J. Immunol. 165, 2101–2107.
Begolka, W.S., Haynes, L.M., Olson, J.K., Padilla, J., Neville, K.L., Dal Canto,
M., Palma, J., Kim, B.S., Miller, S.D., 2001. CD8-deficient SJL mice
display enhanced susceptibility to Theiler's virus infection and increased
demyelinating pathology. J. NeuroVirol. 7, 409–420.
Brahic, M., Bureau, J.F., Michiels, T., 2005. The genetics of the persistent
infection and demyelinating disease caused by Theiler's virus. Annu. Rev.
Microbiol. 59, 279–298.
Clatch, R.J., Miller, S.D., Metzner, R., Dal Canto, M.C., Lipton, H.L., 1990.
Monocytes/macrophages isolated from the mouse central nervous system
contain infectious Theiler's murine encephalomyelitis virus (TMEV).
Virology 176, 244–254.
Crane, M.A., Jue, C., Mitchell, M., Lipton, H., Kim, B.S., 1990. Detection of
restricted predominant epitopes of Theiler's murine encephalomyelitis virus
capsid proteins expressed in the lambda gt11 system: differential patterns of
antibody reactivity among different mouse strains. J. Neuroimmunol. 27,
173–186.
Dethlefs, S., Escriou, N., Brahic, M., van der Werf, S., Larsson-Sciard, E.L.,
1997. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T
lymphocytes restricted to the same immunodominant VP2 epitope in
C57BL/6 mice. J. Virol. 71, 5361–5365.
Feltkamp, M.C., Vierboom, M.P., Kast, W.M., Melief, C.J., 1994. Efficient
MHC class I-peptide binding is required but does not ensure MHC class I-
restricted immunogenicity. Mol. Immunol. 31, 1391–1401.
Feltkamp, M.C., Vierboom, M.P., Toes, R.E., Ossendorp, F., ter Schegget, J.,
Melief, C.J., Kast, W.M., 1995. Competition inhibition of cytotoxic T-
lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL
epitopes than induction of antibody-detected MHC class I stabilization.
Immunol. Lett. 47, 1–8.
Feuer, R., Mena, I., Pagarigan, R., Slifka, M.K., Whitton, J.L., 2002. Cell cycle
status affects coxsackievirus replication, persistence, and reactivation in
vitro. J. Virol. 76, 4430–4440.
Fuller, A.C., Kang, B., Kang, H.K., Yahikozowa, H., Dal Canto, M.C., Kim,
B.S., 2005. Gender bias in Theiler's virus-induced demyelinating disease
correlates with the level of antiviral immune responses. J. Immunol. 175,
3955–3963.
Goulder, P.J., Watkins, D.I., 2004. HIV and SIV CTL escape: implications for
vaccine design. Nat. Rev., Immunol. 4, 630–640.
Granucci, F., Foti, M., Ricciardi-Castagnoli, P., 2005. Dendritic cell biology.
Adv. Immunol. 88, 193–233.
Greter, M., Heppner, F.L., Lemos, M.P., Odermatt, B.M., Goebels, N., Laufer,
T., Noelle, R.J., Becher, B., 2005. Dendritic cells permit immune invasion of
the CNS in an animal model of multiple sclerosis. Nat. Med. 11, 328–334.
Horton, H., Russell, N., Moore, E., Frank, I., Baydo, R., Havenar-Daughton, C.,
Lee, D., Deers, M., Hudgens, M., Weinhold, K., McElrath, M.J., 2004.
Correlation between interferon-g secretion and cytotoxicity, in virus-specific
memory T cells. J. Infect. Dis. 190, 1692–1696.
Hou, W., Wu, Y., Sun, S., Shi, M., Sun, Y., Yang, C., Pei, G., Gu, Y., Zhong, C.,
Sun, B., 2003. Pertussis toxin enhances Th1 responses by stimulation of
dendritic cells. J. Immunol. 170, 1728–1736.
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu,
S., Steinman, R.M., 1992. Generation of large numbers of dendritic cells
from mouse bone marrow cultures supplemented with granulocyte/
macrophage colony-stimulating factor. J. Exp. Med. 176, 1693–1702.
Johnson, A.J., Njenga, M.K., Hansen, M.J., Kuhns, S.T., Chen, L., Rodriguez,
M., Pease, L.R., 1999. Prevalent class I-restricted T-cell response to the
Theiler's virus epitope Db:VP2121–130 in the absence of endogenous CD4
help, tumor necrosis factor alpha, gamma interferon, perforin, or costimula-
tion through CD28. J. Virol. 73, 3702–3708.
Kang, B.S., Lyman, M.A., Kim, B.S., 2002a. Differences in avidity and epitope
recognition of CD8+ T cells infiltrating the central nervous systems of SJL/J
mice infected with BeAn and DA strains of Theiler's murine encephalo-
myelitis virus. J. Virol. 76, 11780–11784.
Kang, B.S., Lyman, M.A., Kim, B.S., 2002b. The majority of infiltrating CD8+
T cells in the central nervous system of susceptible SJL/J mice infected withTheiler's virus are virus specific and fully functional. J. Virol. 76,
6577–6585.
Kang, B., Kang, H.K., Kim, B.S., 2005a. Identification of capsid epitopes of
Theiler's virus recognized by CNS-infiltrating CD4+ T cells from virus-
infected C57BL/6 mice. Virus Res. 108, 57–61.
Kang, B.S., Palma, J.P., Lyman, M.A., Dal Canto, M., Kim, B.S., 2005b.
Antibody response is required for protection from Theiler's virus-induced
encephalitis in C57BL/6 mice in the absence of CD8+ T cells. Virology 340,
84–94.
Kim, B.S., Palma, J.P., Inoue, A., Koh, C.S., 2000. Pathogenic immunity in
Theiler's virus-induced demyelinating disease: a viral model for multiple
sclerosis. Arch. Immunol. Ther. Exp. 48, 373–379.
Kim, K.S., Tracy, S., Tapprich, W., Bailey, J., Lee, C.K., Kim, K., Barry, W.H.,
Chapman, N.M., 2005. 5′-Terminal deletions occur in coxsackievirus B3
during replication in murine hearts and cardiac myocyte cultures and
correlate with encapsidation of negative-strand viral RNA. J. Virol. 79,
7024–7041.
Lipton, H.L., Kumar, A.S., Trottier, M., 2005. Theiler's virus persistence in the
central nervous system of mice is associated with continuous viral
replication and a difference in outcome of infection of infiltrating
macrophages versus oligodendrocytes. Virus Res. 111, 214–223.
Liuzzi, G.M., Riccio, P., Dal Canto, M.C., 1995. Release of myelin basic
protein-degrading proteolytic activity from microglia and macrophages after
infection with Theiler's murine encephalomyelitis virus: comparison
between susceptible and resistant mice. J. Neuroimmunol. 62, 91–102.
Ljunggren, H.G., Stam, N.J., Ohlen, C., Neefjes, J.J., Hoglund, P., Heemels,
M.T., Bastin, J., Schumacher, T.N., Townsend, A., Karre, K., et al., 1990.
Empty MHC class I molecules come out in the cold. Nature 346, 476–480.
Lyman, M.A., Lee, H.G., Kang, B.S., Kang, H.K., Kim, B.S., 2002. Capsid-
specific cytotoxic T lymphocytes recognize three distinct H-2Db-restricted
regions of the BeAn strain of Theiler's virus and exhibit different cytokine
profiles. J. Virol. 76, 3125–3134.
Lyman, M.A., Myoung, J., Mohindru, M., Kim, B.S., 2004. Quantitative, not
qualitative, differences in CD8+ T cell responses to Theiler's murine
encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J
mice. Eur. J. Immunol. 34, 2730–2739.
McMahon, E.J., Bailey, S.L., Castenada, C.V., Waldner, H., Miller, S.D., 2005.
Epitope spreading initiates in the CNS in two mouse models of multiple
sclerosis. Nat. Med. 11, 335–339.
Mena, I., Roussarie, J.P., Brahic, M., 2004. Infection of macrophage primary
cultures by persistent and nonpersistent strains of Theiler's virus: role of
capsid and noncapsid viral determinants. J. Virol. 78, 13356–13361.
Mendez-Fernandez, Y.V., Johnson, A.J., Rodriguez, M., Pease, L.R., 2003.
Clearance of Theiler's virus infection depends on the ability to generate a
CD8+ T cell response against a single immunodominant viral peptide. Eur. J.
Immunol. 33, 2501–2510.
Murray, P.D., McGavern, D.B., Lin, X., Njenga, M.K., Leibowitz, J., Pease,
L.R., Rodriguez, M., 1998. Perforin-dependent neurologic injury in a viral
model of multiple sclerosis. J. Neurosci. 18, 7306–7314.
Njenga, M.K., Pavelko, K.D., Baisch, J., Lin, X., David, C., Leibowitz, J.,
Rodriguez, M., 1996. Theiler's virus persistence and demyelination in
major histocompatibility complex class II-deficient mice. J. Virol. 70,
1729–1737.
Palma, J.P., Lee, H.G., Mohindru, M., Kang, B.S., Dal Canto, M., Miller, S.D.,
Kim, B.S., 2001. Enhanced susceptibility to Theiler's virus-induced
demyelinating disease in perforin-deficient mice. J. Neuroimmunol. 116,
125–135.
Palma, J.P., Yauch, R.L., Kang, H.K., Lee, H.G., Kim, B.S., 2002. Preferential
induction of IL-10 in APC correlates with a switch from Th1 to Th2
response following infection with a low pathogenic variant of Theiler's
virus. J. Immunol. 168, 4221–4230.
Pevear, D.C., Calenoff, M., Rozhon, E., Lipton, H.L., 1987. Analysis of the
complete nucleotide sequence of the picornavirus Theiler's murine
encephalomyelitis virus indicates that it is closely related to cardioviruses.
J. Virol. 61, 1507–1516.
Pircher, H., Moskophidis, D., Rohrer, U., Burki, K., Hengartner, H.,
Zinkernagel, R.M., 1990. Viral escape by selection of cytotoxic T cell-
resistant virus variants in vivo. Nature 346, 629–633.
171J. Myoung et al. / Virology 360 (2007) 159–171Pullen, L.C., Miller, S.D., Dal Canto, M.C., Kim, B.S., 1993. Class I-deficient
resistant mice intracerebrally inoculated with Theiler's virus show an
increased T cell response to viral antigens and susceptibility to demyelina-
tion. Eur. J. Immunol. 23, 2287–2293.
Rammensee, H.G., Friede, T., Stevanoviic, S., 1995. MHC ligands and peptide
motifs: first listing. Immunogenetics 41, 178–228.
Rivera-Quinones, C., McGavern, D., Schmelzer, J.D., Hunter, S.F., Low, P.A.,
Rodriguez, M., 1998. Absence of neurological deficits following extensive
demyelination in a class I-deficient murine model of multiple sclerosis. Nat.
Med. 4, 187–193.
Rossi, C.P., Delcroix, M., Huitinga, I., McAllister, A., van Rooijen, N.,
Claassen, E., Brahic, M., 1997. Role of macrophages during Theiler's virus
infection. J. Virol. 71, 3336–3340.Shah, A.H., Lipton, H.L., 2002. Low-neurovirulence Theiler's viruses use sialic
acid moieties on N-linked oligosaccharide structures for attachment.
Virology 304, 443–450.
Velloso, L.M., Michaelsson, J., Ljunggren, H.G., Schneider, G., Achour, A.,
2004. Determination of structural principles underlying three different
modes of lymphocytic choriomeningitis virus escape from CTL recognition.
J. Immunol. 172, 5504–5511.
Zhou, L., Lin, X., Green, T.J., Lipton, H.L., Luo, M., 1997. Role of
sialyloligosaccharide binding in Theiler's virus persistence. J. Virol. 71,
9701–9712.
Zhou, L., Luo, Y., Wu, Y., Tsao, J., Luo, M., 2000. Sialylation of the host
receptor may modulate entry of demyelinating persistent Theiler's virus.
J. Virol. 74, 1477–1485.
